Literature DB >> 12964119

Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.

Emmanouil Papasavvas1, Johan K Sandberg, Richard Rutstein, Elizabeth C Moore, Agnieszka Mackiewicz, Brian Thiel, Maxwell Pistilli, Rayford R June, Kimberly A Jordan, Robert Gross, Vernon C Maino, Douglas F Nixon, Luis J Montaner.   

Abstract

The present study assessed antiviral T cell immune responses in 48 human immunodeficiency virus (HIV)-infected children with a stable or decreasing CD4(+) T cell counts and different levels of viral control, in the presence or absence of antiretroviral therapy. Children with full (<40 copies/mL) or partial (<50,000 copies/mL) virus suppression and with a history of stable CD4(+) T cell counts had significantly increased levels of anti-HIV CD4(+) T cell lymphoproliferative responses, lower levels of CD38(+), and higher CD8(+)/CD28(+) T cell percentage, compared with those in treated children with a lack of virus suppression (>50,000 copies/mL). Levels of anti-HIV CD8(+) T cell activity, although higher in treated children with a lack of virus suppression, were not significantly different between the groups. Although levels of anti-HIV CD4(+) and CD8(+) T cell responses were not associated, these levels of responses were associated with the percentage of specific T cell subsets. Overall, a history of stable CD4(+) T cell counts, as a result of therapy that imparted full or partial virus suppression, was associated with increased levels of anti-HIV CD4(+) T helper responses and decreased T cell activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964119     DOI: 10.1086/377645

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  The role of race and gender in T cell responses in children perinatally infected with HIV-1.

Authors:  Andrea Kovacs; Maria C Villacres
Journal:  J Infect Dis       Date:  2005-10-05       Impact factor: 5.226

2.  Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.

Authors:  Geoffrey J Gorse; Ramona E Simionescu; Gira B Patel
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?

Authors:  M Hainaut; V Verscheure; M Ducarme; L Schandené; J Levy; F Mascart
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

4.  Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate.

Authors:  Julia G Prado; Andrew Prendergast; Christina Thobakgale; Claudia Molina; Gareth Tudor-Williams; Thumbi Ndung'u; Bruce D Walker; Philip Goulder
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.

Authors:  Emmanouil Papasavvas; Jay R Kostman; Brian Thiel; Maxwell Pistilli; Agnieszka Mackiewicz; Andrea Foulkes; Robert Gross; Kimberly A Jordan; Douglas F Nixon; Robert Grant; Jean-Francois Poulin; Joseph M McCune; Karam Mounzer; Luis J Montaner
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.542

6.  Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control.

Authors:  Aaruni Khanolkar; William J Muller; Bridget M Simpson; Jillian Cerullo; Ruth Williams; Sun Bae Sowers; Kiana Matthews; Sara Mercader; Carole J Hickman; Richard T D'Aquila; Guorong Liu
Journal:  Commun Med (Lond)       Date:  2022-03-04

7.  Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.

Authors:  Emmanouil Papasavvas; Jay R Kostman; Karam Mounzer; Robert M Grant; Robert Gross; Cele Gallo; Livio Azzoni; Andrea Foulkes; Brian Thiel; Maxwell Pistilli; Agnieszka Mackiewicz; Jane Shull; Luis J Montaner
Journal:  PLoS Med       Date:  2004-12-28       Impact factor: 11.069

8.  Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.

Authors:  Jérôme Le Chenadec; Daniel Scott-Algara; Stéphane Blanche; Céline Didier; Thomas Montange; Jean-Paul Viard; Catherine Dollfus; Véronique Avettand-Fenoel; Christine Rouzioux; Josiane Warszawski; Florence Buseyne
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.